Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Cash from Investing Activities: 2014-2024

Historic Cash from Investing Activities for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to -$120.2 million.

  • AC Immune's Cash from Investing Activities rose 2567.06% to $59.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.3 million, marking a year-over-year increase of 200.32%. This contributed to the annual value of -$120.2 million for FY2024, which is 262.41% down from last year.
  • Per AC Immune's latest filing, its Cash from Investing Activities stood at -$120.2 million for FY2024, which was down 262.41% from $74.0 million recorded in FY2023.
  • Over the past 5 years, AC Immune's Cash from Investing Activities peaked at $74.0 million during FY2023, and registered a low of -$120.2 million during FY2024.
  • Over the past 3 years, AC Immune's median Cash from Investing Activities value was $24.7 million (recorded in 2022), while the average stood at -$7.2 million.
  • Per our database at Business Quant, AC Immune's Cash from Investing Activities crashed by 287.41% in 2021 and then soared by 200.02% in 2023.
  • Over the past 5 years, AC Immune's Cash from Investing Activities (Yearly) stood at $31.3 million in 2020, then tumbled by 287.41% to -$58.7 million in 2021, then surged by 142.00% to $24.7 million in 2022, then skyrocketed by 200.02% to $74.0 million in 2023, then plummeted by 262.41% to -$120.2 million in 2024.